@dontfollowme
Other than reporting that safety and futility analysis does not show reason to stop the trial at this very early point, no trial data can be released. It would invalidate the trial.
Please stop the unreasonable / ill-informed demands of Mesoblast. You are simply misleading yourself and/ or other investors. Deliberately?
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial, page-60
-
- There are more pages in this discussion • 240 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |